564 related articles for article (PubMed ID: 12270869)
21. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats.
Kim S; Sada T; Mizuno M; Ikeda M; Yano M; Miura K; Yamanaka S; Koike H; Iwao H
Hypertens Res; 1997 Jun; 20(2):133-42. PubMed ID: 9220278
[TBL] [Abstract][Full Text] [Related]
23. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.
Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K
Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230
[TBL] [Abstract][Full Text] [Related]
24. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Zhao Q; Ishibashi M; Hiasa K; Tan C; Takeshita A; Egashira K
Hypertension; 2004 Sep; 44(3):264-70. PubMed ID: 15262905
[TBL] [Abstract][Full Text] [Related]
25. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
Ogawa Y; Tamura N; Chusho H; Nakao K
Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
27. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
28. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
Flesch M; Höper A; Dell'Italia L; Evans K; Bond R; Peshock R; Diwan A; Brinsa TA; Wei CC; Sivasubramanian N; Spinale FG; Mann DL
Circulation; 2003 Aug; 108(5):598-604. PubMed ID: 12874189
[TBL] [Abstract][Full Text] [Related]
29. Essential role of AT1A receptor in the development of 2K1C hypertension.
Cervenka L; Horácek V; Vanecková I; Hubácek JA; Oliverio MI; Coffman TM; Navar LG
Hypertension; 2002 Nov; 40(5):735-41. PubMed ID: 12411470
[TBL] [Abstract][Full Text] [Related]
30. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
Harada M; Itoh H; Nakagawa O; Ogawa Y; Miyamoto Y; Kuwahara K; Ogawa E; Igaki T; Yamashita J; Masuda I; Yoshimasa T; Tanaka I; Saito Y; Nakao K
Circulation; 1997 Nov; 96(10):3737-44. PubMed ID: 9396478
[TBL] [Abstract][Full Text] [Related]
31. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
32. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
33. Biphasic regulation of Na+-HCO3- cotransporter by angiotensin II type 1A receptor.
Horita S; Zheng Y; Hara C; Yamada H; Kunimi M; Taniguchi S; Uwatoko S; Sugaya T; Goto A; Fujita T; Seki G
Hypertension; 2002 Nov; 40(5):707-12. PubMed ID: 12411466
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
35. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
[TBL] [Abstract][Full Text] [Related]
36. Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan.
Holtwick R; Baba HA; Ehler E; Risse D; Vobeta M; Gehrmann J; Pierkes M; Kuhn M
J Cardiovasc Pharmacol; 2002 Nov; 40(5):725-34. PubMed ID: 12409981
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
[TBL] [Abstract][Full Text] [Related]
39. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
